ALFA FinderBSE filing, NSE: SYSTMTXC. Summary written from the filing by ALFA Finder's alert engine.
Systematix Corporate Services Ltd: key numbers
- Share price
- ₹82.10
- Market cap
- ₹1,121 Cr
- Revenue (annual)
- ₹146.2 Cr
- Net profit (annual)
- ₹13.85 Cr
- P/E (TTM)
- -746.4×Sector 20.8×
- Promoter holding
- 70.58%+0.00% QoQ
- FII holding
- 4.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Systematix Corporate Services Ltd
All →Systematix Corporate Services Employee Stock Options
Systematix Corporate Services granted 19,09,179 ESOPs under its ESOP 2025 scheme at an exercise price of Rs. 63.45. Options vest later; no cash is involved.
Systematix Corporate Services Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹57.8 Cr (+3.7% YoY); PAT ₹13.1 Cr (-9% YoY). H1 PAT ₹8.2 Cr (-67%). Management attributes weak profitability to upfront Private Wealth investment.
Systematix Corporate Services Q2 FY27 Results: Net Profit ₹13.1 Cr, Down 9.7% YoY
Systematix Corporate Services Ltd reported revenue from operations of ₹57.8 Cr (+3.8% YoY) and net profit of ₹13.1 Cr (-9.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹13.1 Cr · -9.7% YoY
Systematix Corporate Services Board Meeting Date
Systematix Corporate Services has intimated a board meeting on November 12, 2026 to consider its standalone and consolidated unaudited results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results announcement.
Systematix Corporate Services Other Announcement
Systematix Corporate Services Ltd has filed its quarterly shareholding pattern for the period ended 30th September 2026 as per Regulation 31 of SEBI LODR.
Systematix Corporate Services Merger & Restructuring Worth ₹10 Cr
Systematix Corporate Services will invest ₹10 Crore in its wholly-owned subsidiary, Systematix Wealth & Asset Services, by subscribing to a rights issue of equity shares.
- Value
- ₹10.00 Cr
Other results update announcements
All →Niyogin Fintech Results Update
Niyogin Fintech's CEO letter reports Q2 FY27 net revenue of Rs 23.9 Cr and PBT ex-ESOP loss of Rs 4.4 Cr. Composite scheme awaits final NCLT approval.
Prakash Pipes Results Update
Prakash Pipes reported Q2 FY27 net sales of ₹259 crores, up 43%, with PAT rising 72% to ₹16 crores. Half-year net sales reached ₹501 crores.
Gaudium IVF And Women Health Results Update
Gaudium IVF reported Q2 FY27 revenue of ₹37.4 crore, up 17.9% YoY, with H1 revenue at ₹56.8 crore. Two new IVF hubs commenced operations during the quarter.
TARC Results Update
TARC reported H1 FY2027 total income of ₹352.78 crore and PAT of ₹27 crore. Q2 PAT was ₹4.05 crore, versus a loss in Q2 FY2026.
Balaxi Pharmaceuticals Results Update
Balaxi Pharmaceuticals issued a press release on Q2 FY27 results, with revenue up 45% and PAT up 450% year-on-year. EBITDA rose 338% to ₹512.07 lakh.
Q-Line Biotech Results Update
Q-Line Biotech's H1 FY27 revenue rose 5.83% while EBITDA grew 10.02%, but PAT fell 8.06%. The release also covers a proposed 70% stake acquisition in Heidelco.